2014 Fiscal Year Final Research Report
CNB-001, a synthesized derivative of curcumin, activates CaMKII and enhances memory
| Project/Area Number |
24790540
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Applied pharmacology
|
|---|
| Research Institution | Musashino University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Keywords | クルクミン / 海馬 / 長期増強 / 記憶 / CaMKⅡ |
|---|
| Outline of Final Research Achievements |
We have recently demonstrated that oral administration of CNB-001, a synthesized pyrazole derivative of curcumin, enhances memory in a rat object recognition test. CNB-001 could be useful in the development of therapeutic drugs for senile dementia.
This study investigated mechanisms underlying the memory-enhancing effect of CNB-001, and found that CNB-001 promoted NMDA receptor- and CaMKII-dependent long-term potentiation (LTP) of rat hippocampal slices, not via the MAP kinase or PKC cascade.
|
| Free Research Field |
応用薬理学
|
